At a glance
- Originator Osaka City University; Suntory
- Class Antifungals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Mycoses
Most Recent Events
- 17 Jul 2001 Discontinued-Preclinical for Mycoses in Japan (Unknown route)
- 29 Aug 1996 New profile
- 29 Aug 1996 Preclinical development for Mycoses in Japan (Unknown route)